Bioqual (OTCMKTS:BIOQ) Posts Earnings Results

Bioqual (OTCMKTS:BIOQ) released its quarterly earnings data on Tuesday. The company reported ($0.28) earnings per share for the quarter, Zacks reports. The business had revenue of $9.85 million during the quarter. Bioqual had a negative return on equity of 1.74% and a negative net margin of 1.32%.

Bioqual Price Performance

OTCMKTS BIOQ opened at $40.00 on Thursday. The firm has a market cap of $35.60 million, a price-to-earnings ratio of -57.14 and a beta of -0.07. The business has a 50-day moving average price of $41.12 and a 200-day moving average price of $45.06. Bioqual has a twelve month low of $33.00 and a twelve month high of $66.10.

Bioqual Company Profile

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.